Brainstorm Cell Therapeutics Inc.
Peter Joe Pitts (Executive Chairman) reports BCLI insider transactions
About this filing
Brainstorm Cell Therapeutics Inc. (BCLI) filed Form 4 (insider transaction) with the SEC on Jul 28, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Peter Joe Pitts · Executive Chairman, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | A · grantStock Option (Right to Buy)Footnotes F1, F2 | +900,000 | $0.00 | $0.00 | 900,000 | Direct |
Footnotes
- F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
- F2 The stock options vest over 48 months, with 25% vesting on July 24, 2027 and 1/48th vesting monthly thereafter, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
More BCLI filings
- 10-Q
Filed Nov 16, 2026
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Aug 14, 2026
- 8-K
Filed Aug 14, 2026
- 8-K
Filed Jul 30, 2026
- 4
Filed Jul 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.